One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-125039
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 6 |
Affiliation: Humanitas University, Istituti di Ricovero e Cura a Carattere Scientifico, Massachusetts General Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, Northside Hospital, Emory University, Hôpital Saint-Antoine, Sorbonne Université, James Cancer Hospital, The Ohio State University, University of Rennes, Centre Hospitalier Universitaire de Rennes, Dana-Farber Cancer Institute, City of Hope, Hospital of the University of Pennsylvania, Hackensack University Medical Center, The University of Texas MD Anderson Cancer Center, University of Kansas Medical Center, Harvard University, Beth Israel Deaconess Medical Center, Centre Hospitalier Universitaire d'Angers, Institute Paoli-Calmettes, Stanford Medicine, Stanford University, Fondazione Humanitas per la Ricerca, Medical College of Wisconsin, University of Bologna, Istituto di Ematologia di Bologna, Mario Negri Institute for Pharmacological Research, IRCCS Humanitas Research Hospital, University of Washington, Fred Hutch Cancer Center, Mayo Clinic, Institut Jules Bordet, Ohio State University Hospital, University of Angers, Vanderbilt University Medical CenterSafety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classical Hodgkin Lymphoma: Analysis of a Large International Cohort
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
